Effect of SERMs on the Uterus and Menopausal Symptoms

Overview

Journal J Endocrinol Invest

Publisher Springer

Specialty Endocrinology

Date 1999 Oct 26

PMID 10532250

Citations 1

Authors

M Doren

Affiliations

Soon will be listed here.

Citing Articles

Estradiol-intranasal: a review of its use in the management of menopause.

Dooley M, Spencer C, Ormrod D Drugs. 2002; 61(15):2243-62.

PMID: 11772138 DOI: 10.2165/00003495-200161150-00012.

References

Sultana C, Walters M . Estrogen and urinary incontinence in women. Maturitas. 1994; 20(2-3):129-38. DOI: 10.1016/0378-5122(94)90008-6. View

Hilditch J, Lewis J, Peter A, van Maris B, Ross A, Franssen E . A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas. 1996; 24(3):161-75. DOI: 10.1016/s0378-5122(96)82006-8. View

Shughrue P, Lane M, Merchenthaler I . Regulation of progesterone receptor messenger ribonucleic acid in the rat medial preoptic nucleus by estrogenic and antiestrogenic compounds: an in situ hybridization study. Endocrinology. 1997; 138(12):5476-84. DOI: 10.1210/endo.138.12.5595. View

Boulet M, Oddens B, Lehert P, Vemer H, Visser A . Climacteric and menopause in seven South-east Asian countries. Maturitas. 1994; 19(3):157-76. DOI: 10.1016/0378-5122(94)90068-x. View

BAKER V, Draper M, Paul S, Allerheiligen S, Glant M, Shifren J . Reproductive endocrine and endometrial effects of raloxifene hydrochloride, a selective estrogen receptor modulator, in women with regular menstrual cycles. J Clin Endocrinol Metab. 1998; 83(1):6-13. DOI: 10.1210/jcem.83.1.4448. View

Oldenhave A, Jaszmann L, HASPELS A, Everaerd W . Impact of climacteric on well-being. A survey based on 5213 women 39 to 60 years old. Am J Obstet Gynecol. 1993; 168(3 Pt 1):772-80. DOI: 10.1016/s0002-9378(12)90817-0. View

Clayden J, Bell J, Pollard P . Menopausal flushing: double-blind trial of a non-hormonal medication. Br Med J. 1974; 1(5905):409-12. PMC: 1633257. DOI: 10.1136/bmj.1.5905.409. View

Beyene Y . Cultural significance and physiological manifestations of menopause. A biocultural analysis. Cult Med Psychiatry. 1986; 10(1):47-71. DOI: 10.1007/BF00053262. View

Mohyi D, Tabassi K, Simon J . Differential diagnosis of hot flashes. Maturitas. 1997; 27(3):203-14. DOI: 10.1016/s0378-5122(97)83974-6. View

10.

Nickelsen T, Lufkin E, Riggs B, Cox D, Crook T . Raloxifene hydrochloride, a selective estrogen receptor modulator: safety assessment of effects on cognitive function and mood in postmenopausal women. Psychoneuroendocrinology. 1999; 24(1):115-28. DOI: 10.1016/s0306-4530(98)00041-9. View

11.

Tataryn I, Meldrum D, Lu K, Frumar A, Judd H . LH, FSH and skin temperaure during the menopausal hot flash. J Clin Endocrinol Metab. 1979; 49(1):152-4. DOI: 10.1210/jcem-49-1-152. View

12.

Greene J . Constructing a standard climacteric scale. Maturitas. 1998; 29(1):25-31. DOI: 10.1016/s0378-5122(98)00025-5. View

13.

Kaufert P . Women and their health in the middle years: a Manitoba project. Soc Sci Med. 1984; 18(3):279-81. DOI: 10.1016/0277-9536(84)90091-1. View

14.

Draper M, Flowers D, Huster W, Neild J, Harper K, Arnaud C . A controlled trial of raloxifene (LY139481) HCl: impact on bone turnover and serum lipid profile in healthy postmenopausal women. J Bone Miner Res. 1996; 11(6):835-42. DOI: 10.1002/jbmr.5650110615. View

15.

JOHANNISSON E, Holinka C, Arrenbrecht S . Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium. Int J Fertil Womens Med. 1997; 42 Suppl 2:388-98. View

16.

Lufkin E, Whitaker M, Nickelsen T, Argueta R, Caplan R, Knickerbocker R . Treatment of established postmenopausal osteoporosis with raloxifene: a randomized trial. J Bone Miner Res. 1998; 13(11):1747-54. DOI: 10.1359/jbmr.1998.13.11.1747. View

17.

Kaufert P, Gilbert P, Tate R . The Manitoba Project: a re-examination of the link between menopause and depression. Maturitas. 1992; 14(2):143-55. DOI: 10.1016/0378-5122(92)90006-p. View

18.

Ross A, Boyd M, Colgan T, Ferenczy A, FUGERE P, Lorrain J . Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology. Obstet Gynecol. 1993; 82(5):773-9. View

19.

Assikis V, Jordan V . Gynecologic effects of tamoxifen and the association with endometrial carcinoma. Int J Gynaecol Obstet. 1995; 49(3):241-57. DOI: 10.1016/0020-7292(95)02387-r. View

20.

Mairon N, JOYCE C, Le Gal M . Quality of life after the menopause: influence of hormonal replacement therapy. Am J Obstet Gynecol. 1994; 170(2):618-24. DOI: 10.1016/s0002-9378(94)70239-x. View